Are breast cancer patients with suboptimal adherence to cardiovascular treatment more likely to discontinue adjuvant endocrine therapy? Competing risk survival analysis in a nationwide cohort of postmenopausal women

BACKGROUND: High rates of discontinuation undermine the effectiveness of adjuvant endocrine therapy (AET) among hormone-receptive breast cancer patients. Patient prognosis also relies on the successful management of cardiovascular risk, which affects a high proportion of postmenopausal women. As wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Artignan, Juliette, Capmas, Perrine, Panjo, Henri, Constantinou, Panayotis, Pelletier-Fleury, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675896/
https://www.ncbi.nlm.nih.gov/pubmed/38001491
http://dx.doi.org/10.1186/s12916-023-03156-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675896/
https://www.ncbi.nlm.nih.gov/pubmed/38001491
http://dx.doi.org/10.1186/s12916-023-03156-3

Ejemplares similares